Klonal Laboratorios Competitors and Similar CompaniesClear all

Klonal Laboratorios's competitors and similar companies include Yiling Pharmaceutical, Roemmers, Laboratorio Internacional Argentino and Jiangsu Hengrui Pharmaceuticals.

	Klonal Laboratorios Klonal Laboratorios is a manufacturer and supplier of pharmaceutical products.	Yiling Pharmaceutical Shijiazhuang Yiling Pharmaceutical (石家庄以岭药业股份有限公司) is a company that develops, produces, and sells medicine.	Roemmers Roemmers is a company that produces, develops, and markets human medicines.	Laboratorio Internacional Argentino Laboratorio Internacional Argentino is a company that manufactures and markets pharmaceuticals.	Jiangsu Hengrui Pharmaceuticals Jiangsu Hengrui Pharmaceuticals (江苏恒瑞医药股份有限公司) is a company that manufactures and distributes pharmaceutical tablets, injections, and raw materials.
Founding Date	Founding Date 1975	Founding Date 1992	Founding Date 1921	Founding Date 1957	Founding Date 1970
Type	Type Private	Type Public	Type Private	Type Subsidiary	Type Public
Tags	Tags Healthcare distribution drug development pharmacy	Tags Healthcare distribution drug development pharmacy	Tags Healthcare distribution drug development pharmacy	Tags Healthcare distribution drug development pharmacy	Tags Healthcare distribution drug development pharmacy
Locations	Locations Bernal, AR HQ Ihd, AR	Locations Shijiazhuang, CN HQ	Locations Olivos, AR HQ	Locations AR HQ	Locations Lianyungang, CN HQ
Employees	Employees 230	Employees 11,70822% decrease	Employees 1,786	Employees 1401% decrease	Employees 20,238
Valuation ($)	Valuation ($) N/A	Valuation ($) 4 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 42.2 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥7.7b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥27.7b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods ¥2.8b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥4.4b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit ¥4.9b (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit ¥27b (FY, 2025)
Net income	Net income N/A	Net income ¥1.3b (FY, 2025)	Net income N/A	Net income N/A	Net income ¥7.7b (FY, 2025)